ETC-588 large unilamellar vesicles: ESPR began a dose-ranging U.S. Phase II trial of ETC-588 in 32 patients with vascular disease. Patients will receive an intr

Esperion Therapeutics Inc. (ESPR), Ann Arbor, Mich.
Product: ETC-588 large unilamellar

Read the full 110 word article

How to gain access

Continue reading with a
two-week free trial.